Aytu Biopharma (AYTU) Current Deferred Tax Assets (2015)

Aytu Biopharma's (AYTU) quarterly Current Deferred Tax Assets came in at $94211.0 in Q3 2015, up 127.41% on a QoQ basis from $41427.0 in Q2 2015.

Aytu Biopharma (AYTU) Current Deferred Tax Assets (2015) Analysis & Trends

Aytu Biopharma (AYTU) has 1 years of Current Deferred Tax Assets data on file, last reported at $94211.0 in Q3 2015.

On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $94211.0 in Q3 2015; TTM through Sep 2015 was $94211.0, a N/A change from a year earlier, with the FY2015 full-year figure at $41427.0, up 29.46% from the prior year.
Current Deferred Tax Assets for Q3 2015 stood at $94211.0, up from $41427.0 in the prior quarter.
Over the last five years, Current Deferred Tax Assets for AYTU reached as high as $94211.0 in Q3 2015 and fell as low as $41427.0 in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Aytu Biopharma	1.43 Mn	-25.28 Mn	7.60 Mn

Download Data